Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the ...
Medtronic (NYSE: MDT) announced today that it received CE mark for its ColonPRO fourth-generation software for AI-assisted colonoscopy.
The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.
Medtronic continues to expand the growth opportunities for its hypertension-treating Symplicity Spyral renal denervation system.
Sequel Med Tech and (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration.
Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results